Methylation of five candidate genes frequently silenced by methylation in breast and prostate cancer, including ER, RARβ2 and the cell cycle regulators p16, RASSF1 and CCND2 (cyclin D2) was analyzed in breast tissue. This evidence concerns the gene CCND2 and prostate carcinoma.